Virus-like particles (VLPs) 是一类类似于病毒的纳米级颗粒，它们的结构与真实病毒相似，但不含病毒基因，因此具有较高的生物安全性 [1]。 近年来，VLP技术平台在生物技术领域得到了广泛关注，尤其在疫苗开发、药物载体、基因治疗和免疫调节等领域取得了显著进展 [2]。 1. VLP的结构与分类. VLPs是由病毒结构蛋白组装形成的颗粒，其大小和形状与天然病毒相似 [3]。 根据其来源和结构特点，VLP可以分为多种类型，包括RNA病毒类、DNA病毒类和嵌合病毒类 [4]。 VLPs …

Creative Diagnostics offers the off shelf VLP productions and services to customize VLP generation and package the VLPs to mature ELISA kit, test standard reagent, superantigens and relevant products.

Our product line includes a wide variety of virus families including Parvoviridae (e.g. adeno-associated virus), Retroviridae (e.g. HIV), Flaviviridae (e.g. Hepatitis C virus) and bacteriophages (e.g. Qβ, AP205). Virus-like particles (VLPs) have evolved to become a widely accepted technology, especially in the field of vaccinology.

Virus-like particles (VLPs) are non-infectious nanoscale structures composed of viral proteins. They can be produced in various systems, functioning as delivery carriers of various bio- and nanomaterials. First identified in 1968, these particles self-assemble from viral structural proteins and are efficiently recognized by the immune system.

Creative Biostructure has developed MemPro™ Virus-Like Particles (VLPs) Technology based on our magic Membrane Protein Production platform to efficiently express and purify membrane proteins.

We excel at customization, tailoring VLPs to meet specific client needs, which assures their broad application in vaccine development, targeted drug delivery, and other biopharmaceutical fields.

Compare VLP Kits from leading suppliers on Biocompare. View specifications, prices, citations, reviews, and more.

Virus-like particles (VLPs) are hollow protein particles that are similar in shape to natural virus particles and are self-assembled by one or more structural proteins of viruses. The diameter of VLPs is about 20~200nm, which has a regular spatial structure and superior biocompatibility.

The Cygnus MockV ® RVLP Kit provides a BSL-1 compatible stock solution of non-infectious Retrovirus-like Particles (RVLP), derived endogenously from CHO cell culture, as a spiking agent for viral clearance testing.

We have developed two transmembrane protein display platforms: virus-like particles (VLPs) and nanodiscs. These platforms are designed for functional display of multipass transmembrane proteins in their native conformation.